Cargando…
Novel RNA Markers in Prostate Cancer: Functional Considerations and Clinical Translation
The availability of ultra-high throughput DNA and RNA sequencing technologies in recent years has led to the identification of numerous novel transcripts, whose functions are unknown as yet. Evidence is accumulating that many of these molecules are deregulated in diseases, including prostate cancer,...
Autores principales: | Pickl, Julia M. A., Heckmann, Doreen, Ratz, Leonie, Klauck, Sabine M., Sültmann, Holger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163430/ https://www.ncbi.nlm.nih.gov/pubmed/25250334 http://dx.doi.org/10.1155/2014/765207 |
Ejemplares similares
-
Genome-Based Classification and Therapy of Prostate Cancer
por: Angeles, Arlou Kristina, et al.
Publicado: (2018) -
miR-449a Repression Leads to Enhanced NOTCH Signaling in TMPRSS2:ERG Fusion Positive Prostate Cancer Cells
por: Bauer, Simone, et al.
Publicado: (2021) -
TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells
por: Ratz, Leonie, et al.
Publicado: (2017) -
Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression
por: Pickl, Julia M.A., et al.
Publicado: (2016) -
Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancer
por: Gade, Stephan, et al.
Publicado: (2011)